TY - JOUR
T1 - FOXOs in the impaired heart
T2 - New therapeutic targets for cardiac diseases
AU - Xin, Zhenlong
AU - Ma, Zhiqiang
AU - Jiang, Shuai
AU - Wang, Dongjin
AU - Fan, Chongxi
AU - Di, Shouyin
AU - Hu, Wei
AU - Li, Tian
AU - She, Junjun
AU - Yang, Yang
N1 - Publisher Copyright:
© 2016 Elsevier B.V.
PY - 2017/2/1
Y1 - 2017/2/1
N2 - Cardiac diseases have a high morbidity and mortality and affect the global population. Based on recent accumulating evidence, Forkhead box O (FOXOs) play important roles in cardiac diseases. Therefore, a summary of the current literature on the molecular mechanisms and roles of FOXOs in the heart will provide valuable information. In this review, we first briefly introduce the molecular features of FOXOs. Then, we discuss the regulation and cardiac actions of the FOXO pathways. Based on this background, we expand our discussion to the roles of FOXOs in several major cardiac diseases, such as ischemic cardiac diseases, diabetic cardiomyopathy and myocardial hypertrophy. Then, we describe some methodological problems associated with the FOXO gene-modified animal models. Finally, we discuss potential future directions. The information reviewed here may be significant for the design of future studies and may increase the potential of FOXOs as therapeutic targets.
AB - Cardiac diseases have a high morbidity and mortality and affect the global population. Based on recent accumulating evidence, Forkhead box O (FOXOs) play important roles in cardiac diseases. Therefore, a summary of the current literature on the molecular mechanisms and roles of FOXOs in the heart will provide valuable information. In this review, we first briefly introduce the molecular features of FOXOs. Then, we discuss the regulation and cardiac actions of the FOXO pathways. Based on this background, we expand our discussion to the roles of FOXOs in several major cardiac diseases, such as ischemic cardiac diseases, diabetic cardiomyopathy and myocardial hypertrophy. Then, we describe some methodological problems associated with the FOXO gene-modified animal models. Finally, we discuss potential future directions. The information reviewed here may be significant for the design of future studies and may increase the potential of FOXOs as therapeutic targets.
KW - Cardiac regeneration
KW - Diabetic cardiomyopathy
KW - Forkhead box O
KW - Ischemic cardiac diseases
KW - Myocardial hypertrophy
UR - https://www.scopus.com/pages/publications/85002342359
U2 - 10.1016/j.bbadis.2016.11.023
DO - 10.1016/j.bbadis.2016.11.023
M3 - 文献综述
C2 - 27890702
AN - SCOPUS:85002342359
SN - 0925-4439
VL - 1863
SP - 486
EP - 498
JO - Biochimica et Biophysica Acta - Molecular Basis of Disease
JF - Biochimica et Biophysica Acta - Molecular Basis of Disease
IS - 2
ER -